Malaria is a life-threatening disease caused by parasites of the Plasmodium genus. It is transmitted to humans through infected female Anopheles mosquitoes. It is characterized by cyclic episodes of fever, chills, sweats and other symptoms caused by the invasion and destruction of red blood cells by the parasites. The disease is primarily caused by five Plasmodium species that infect humans: Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale and Plasmodium knowlesi. Of these, Plasmodium falciparum in particular produces the most virulent strain and is responsible for most severe cases and deaths caused by the disease. The disease is highly endemic in tropical and subtropical regions of the world: particularly in sub-Saharan Africa, Asia and Latin America, where favorable climatic conditions such as temperature, humidity and rainfall create excellent conditions for mosquitoes to thrive and transmit the infection.However, it is still one of the most preventable but treatable diseases that affects many parts of the world. The most vulnerable groups thus affected include: children under the age of five; pregnant women; and individuals with weakened immune systems.
Humans are bitten by infected mosquitoes that inject sporozoites, which are the infectious form of the parasite, into the blood. Then, these sporozoites migrate to the liver, invade liver cells, and multiply asexually. Finally, after some time, they develop into another form called merozoite and are released into the blood. The merozoites invade the red blood cells, undergo several cycles of multiplication and break open, releasing more merozoites and then the cycle of infection continues. Such processes come with malarial symptoms like fever and chills that occur regularly at certain periodic intervals according to the particular species of Plasmodium responsible for the condition. Some parasites within the red blood cell differentiate into sexual forms called gametocytes. When a new mosquito bites such an infected individual, it ingests the gametocytes, which develop within the mosquito and fertilize to produce sporozoites, completing the parasite's life cycle and enabling the mosquito to transmit the infection to another human.
Malaria can manifest itself very differently clinically, ranging from mild symptoms to severe forms of manifestation, sometimes leading to death. Symptoms usually include fever, headache, myalgia, nausea and sometimes vomiting, often combined with chills and sweats. Very severe malaria can develop into complications such as so-called cerebral malaria (which causes seizures and a state of coma), severe anemia (due to the breakdown of red cells), acute respiratory distress syndrome, multiple organ failure and death if treatment is not initiated promptly. The diagnosis of malaria involves the detection of parasites in the patient's blood, the most common techniques being the microscopic observation of blood smears or the use of rapid diagnostic tests (RDTs) that detect various antigens produced by the parasite.
Most of the efforts being made today to prevent malaria are based on reducing contact with mosquitoes and controlling the mosquito populations themselves. Preventive measures include insecticide-treated bed nets (ITNs), indoor residual spraying with insecticides (IRS), and prophylactic antimalarial drugs for travelers and individuals in high-risk areas. One of the most important milestones for malaria prevention has been the development and use of malaria vaccines such as RTS,S/AS01, although they have not yet been widely deployed. Treatment of malaria includes antimalarial drugs, with artemisinin-based combination therapy (ACT) being the first-line treatment for infections caused by Plasmodium falciparum. The emergence of drug-resistant strains of Plasmodium has posed challenges to malaria control and elimination efforts.
Apart from posing a serious threat to health, malaria also has widespread socioeconomic impacts, especially in endemic countries. It impoverishes the population by reducing productivity, increasing health care costs, and impeding education and economic opportunities. Endemic countries are facing serious challenges to sustain development in relation to the high prevalence caused by the disease. Apart from all these other efforts by international and national governments and even non-governmental organizations (NGOs), the Roll-Back Malaria Partnership and the Global Fund to Fight AIDS, Tuberculosis and Malaria have been formally formed to fight against malaria. As they advocate for the reduction of morbidity and mortality caused by malaria by increasing access to preventive tools, effective treatments, and strong health systems.
It has plagued humanity for centuries so much so that its presence is recorded in ancient texts, its impact evident in civilizations spanning ages. Advances in scientific understanding of the disease and its transmission since the discovery of the malaria parasite by Alphonse Laveran in 1880 and the identification of the Anopheles mosquito as a vector by Sir Ronald Ross in 1897 should have led to a clear path to developing targeted interventions. However, despite progress, malaria is still a major global health issue due to the adaptability of the Plasmodium parasite, the resilience shown by Anopheles mosquitoes, and the social and logistical barriers that prevent effective and sustainable implementation of control measures.
There are many factors that influence the epidemiology of malaria, including climatic, environmental, biological, and socioeconomic conditions. Climatic factors such as temperature, humidity, and rainfall affect the reproduction and survival of Anopheles mosquitoes, as well as environmental factors such as deforestation, agricultural practices, and urbanization, which can alter the distribution of mosquito populations. Genetic variations in human populations, including the sickle cell trait, are biological factors that influence malaria susceptibility. Socioeconomic conditions such as access to health facilities, education, and living conditions play a role in the malaria burden in different parts of the world.
Malaria directly affects health and security globally. Malaria outbreaks overwhelm health care systems, disrupt communities, and impede progress in other health areas. Today, communities are so interconnected that the disease spreads beyond just endemic geographic areas; in fact, imported cases from non-endemic areas illustrate the need for global programs of surveillance and response. With climate change, the fight against malaria becomes more difficult as changes in temperature and rainfall can increase malaria transmission in areas that were previously non-endemic.
The strategy for global malaria control is initiated by WHO's Global Technical Strategy for Malaria, which sets bold goals in terms of reducing malaria morbidity and mortality and, ultimately, eliminating malaria in endemic countries. The key pillars of this strategy include, among others: achieving universal access to malaria prevention, diagnosis, and treatment; accelerating malaria elimination efforts in targeted areas; and strengthening research and innovations to tackle other new challenges such as drug-and-pesticide resistance.
Research and innovation have continued to advance in the fight against malaria. The new tools now available, from next-generation insecticides to advanced diagnostic opportunities/levels and new antimalarial drugs, lead to a future that is completely different from current intervention limitations. Genomic studies of Plasmodium parasites and Anopheles mosquitoes have yielded important information about the biology and evolution of these parasites, which can guide intervention strategies targeting them. Advances in vaccine development, including efforts to increase the efficacy and ease of access of malaria vaccines, create a bright new path to reducing the burden of disease.
Malaria is a highly complex disease, with international and national public health importance as well as socio-economic and global development implications. It is caused by parasites of the Plasmodium genus and is transmitted by Anopheles mosquitoes that are already infected, leading to a variety of clinical manifestations, which are usually fatal in untreated cases. Combatting malaria is a solid outcome of preventive, therapeutic and healthy systems approaches with worldwide collaboration and open innovation support. Thus, against this backdrop of progress in reducing the malaria burden, challenges such as drug and insect-resistance, temperature changes and socioeconomic barriers herald lasting dedication and investment to control and eliminate malaria. For most populations severely affected, it is malaria that underscores the harsh realities of unequal health access and services globally, reminding us to ensure that no one is left behind in the fight against preventable yet treatable conditions.
